Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury

[1]  M. Ishii,et al.  References Subscriptions Permissions Email Alerts Inhibition of c-Jun NH2-Terminal Kinase Activity Improves Ischemia/Reperfusion Injury in Rat Lungs , 2013 .

[2]  Simon C Watkins,et al.  Deficiency in the c-Jun NH2-terminal kinase signaling pathway confers susceptibility to hyperoxic lung injury in mice. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[3]  U. Shankavaram,et al.  Differential Regulation of Lipopolysaccharide-Induced Monocyte Matrix Metalloproteinase (MMP)-1 and MMP-9 by p38 and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases , 2003, The Journal of Immunology.

[4]  L. Ignarro,et al.  Nuclear Factor- (cid:1) B and Mitogen-activated Protein Kinases Mediate Nitric Oxide-enhanced Transcriptional Expression of Interferon- (cid:2) * , 2003 .

[5]  A. Choi,et al.  Reactive oxygen species and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase mediate hyperoxia-induced cell death in lung epithelium. , 2003, American journal of respiratory cell and molecular biology.

[6]  V. Castranova,et al.  Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: Relationship to alteration in nuclear factor-&kgr;B activity and inflammatory agents* , 2003, Critical care medicine.

[7]  Santanu Chattopadhyay,et al.  Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. , 2002, The Biochemical journal.

[8]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[9]  V. Imbert,et al.  , B and AP-1 in T 84 Cells κ Kinases and the Transcription Factors NF-via Activation of Mitogen-Activated Protein Infection Induces Interleukin-8 Production Escherichia coli Enterohemorrhagic , 2001 .

[10]  Mi Jung Kim,et al.  Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation. , 2002, Journal of applied physiology.

[11]  P. Dhawan,et al.  Correction: A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells , 2001, The Journal of Biological Chemistry.

[12]  P. Dhawan,et al.  A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. , 2002, The Journal of biological chemistry.

[13]  Li Cheng,et al.  p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr. , 2002, Oncogene.

[14]  V. Castranova,et al.  Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. , 2001, American journal of respiratory and critical care medicine.

[15]  M. Karin,et al.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.

[16]  M. Kim,et al.  Inhaled nitric oxide down-regulates intrapulmonary nitric oxide production in lipopolysaccharide-induced acute lung injury , 2001, Critical care medicine.

[17]  S. Tominaga,et al.  A MEK inhibitor, PD98059 enhances IL-1-induced NF-κB activation by the enhanced and sustained degradation of IκBα , 2001 .

[18]  T. van der Poll,et al.  p38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release by Macrophages In Vitro and During Infection In Vivo , 2001, The Journal of Immunology.

[19]  John C. Lee,et al.  SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[20]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[21]  A. Leonardi,et al.  CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Hunninghake,et al.  A constitutive active MEK --> ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation. , 2000, The Journal of biological chemistry.

[23]  J. Christman,et al.  Impact of Basic Research on Tomorrow's MedicineThe Role of Nuclear Factor-κ B in Pulmonary Diseases , 2000 .

[24]  T. Yue,et al.  Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. , 2000, Circulation research.

[25]  J. Nick,et al.  Role of p38 Mitogen-Activated Protein Kinase in a Murine Model of Pulmonary Inflammation1 , 2000, The Journal of Immunology.

[26]  B. Aggarwal,et al.  Human immunodeficiency virus‐1‐tat induces matrix metalloproteinase‐9 in monocytes through protein tyrosine phosphatase‐mediated activation of nuclear transcription factor NF‐κB , 1999 .

[27]  K. Knudtson,et al.  The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). , 1999, The Journal of biological chemistry.

[28]  H. E. Marshall,et al.  Exhaled Nitric Oxide (NO), NO Synthase Activity, and Regulation of Nuclear Factor (NF)- κ B , 1999 .

[29]  L. O’Neill,et al.  Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1. , 1999, Cytokine.

[30]  Xianglin Shi,et al.  Vanadate Induction of NF-κB Involves IκB Kinase β and SAPK/ERK Kinase 1 in Macrophages* , 1999, The Journal of Biological Chemistry.

[31]  Xianglin Shi,et al.  Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK/ERK kinase 1 in macrophages. , 1999, The Journal of biological chemistry.

[32]  S. Weiss,et al.  Characterization of matrix metalloproteinases produced by rat alveolar macrophages. , 1999, American journal of respiratory cell and molecular biology.

[33]  G. Hunninghake,et al.  Both Erk and p38 kinases are necessary for cytokine gene transcription. , 1999, American journal of respiratory cell and molecular biology.

[34]  T. Yano,et al.  Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury. , 1999, Biochemical and biophysical research communications.

[35]  B. Aggarwal,et al.  Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. , 1999, FEBS letters.

[36]  V. Castranova,et al.  Silica-Induced Pulmonary Inflammation in Rats: Activation of NF-κB and Its Suppression by Dexamethasone , 1998 .

[37]  A. Kristof,et al.  Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. , 1998, American journal of respiratory and critical care medicine.

[38]  M. Favata,et al.  Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. , 1998, Journal of immunology.

[39]  K. Mehta,et al.  Differential Roles of Extracellular Signal-regulated Kinase-1/2 and p38MAPK in Interleukin-1β- and Tumor Necrosis Factor-α-induced Low Density Lipoprotein Receptor Expression in HepG2 Cells* , 1998, The Journal of Biological Chemistry.

[40]  A. Brunet,et al.  Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-kappa B and AP-1 transcription factors. , 1998, Journal of immunology.

[41]  L. Traber,et al.  Inhaled nitric oxide selectively reduces pulmonary hypertension after ovine smoke inhalation but does not improve oxygenation. , 1997, The Journal of burn care & rehabilitation.

[42]  J. Christman,et al.  In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. , 1996, Journal of immunology.

[43]  R. Shenkar,et al.  Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. , 1996, Critical care medicine.

[44]  P. Kubes.  Nitric Oxide Affects Microvascular Permeability in the Intact and Inflamed Vasculature , 1995, Microcirculation.

[45]  M. Schmitz,et al.  Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells. , 1995, The Journal of biological chemistry.

[46]  M. Meisterernst,et al.  Interaction of the COOH-terminal Transactivation Domain of p65 NF-κB with TATA-binding Protein, Transcription Factor IIB, and Coactivators (*) , 1995, The Journal of Biological Chemistry.

[47]  W. Greene,et al.  Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene , 1994, Molecular and cellular biology.

[48]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[49]  K. Steinberg,et al.  Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.

[50]  F. Gannon,et al.  A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. , 1994, BioTechniques.

[51]  F. Lane,et al.  In vitro human tumor sensitivity assay using cell counting and sizing. , 1990, American biotechnology laboratory.

[52]  E. Hartree,et al.  Determination of protein: a modification of the Lowry method that gives a linear photometric response. , 1972, Analytical biochemistry.